Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections

Eszter Ostorhazi, Ferenc Rozgonyi, Andras Sztodola, Ferenc Harmos, Ilona Kovalszky, Dora Szabo, Daniel Knappe, Ralf Hoffmann, Marco Cassone, John D. Wade, Robert A. Bonomo, Laszlo Otvos

Research output: Contribution to journalArticle

39 Citations (Scopus)

Fingerprint Dive into the research topics of 'Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections'. Together they form a unique fingerprint.

Medicine & Life Sciences